SCHEMBL12349787

SCHEMBL12349787

C=CCc1ccc(OC(=O)NCCOC(=O)C(=C)C)c(OC)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.60
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
CYP3A4 P08684 2/20 0.53
ALDH1A1 P00352 5/20 0.50
PPARA Q07869 3/20 0.50
PPARG P37231 1/20 0.50
PPARD Q03181 1/20 0.50
PRSS1 P07477 1/20 0.47
ACR P10323 1/20 0.47
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13630525 0.89 PTGS1 (0.44) PTGS1MEN1KMT2ANPC1RAB9A
SCHEMBL12349867 0.88 MGLL (0.47) PTGS1MEN1KMT2ANPC1RAB9A
SCHEMBL16034038 0.84 PTGS1 (0.79) PTGS1MEN1KMT2ANPC1RAB9A
SCHEMBL12349829 0.83 L3MBTL1 (0.44) KMT2ANPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL17488459 0.80 PTGS1 (0.62) PTGS1MEN1KMT2ANPC1RAB9A
SCHEMBL20723694 0.79 MGLL (0.65) PTGS1MEN1KMT2ANPC1RAB9A
SCHEMBL20739904 0.79 MGLL (0.65) PTGS1MEN1KMT2ANPC1RAB9A
SCHEMBL31518918 0.77 PTGS1 (0.67) PTGS1MEN1KMT2ANPC1RAB9A
Eugenyl Acetate SCHEMBL112232 0.76 PTGS1 (1.00) PTGS1MEN1KMT2ANPC1RAB9A
Eugenyl Acetate SCHEMBL29802968 0.76 PTGS1 (1.00) PTGS1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190467-A1 Biological Polysiloxanes VISION CRC LIMITED (AU) 2011-08-04 US disclosed
US-20110190467-A1 Biological Polysiloxanes VISION CRC LIMITED (AU) 2011-08-04 US disclosed
US-20090276042-A1 Biological Polysiloxanes VISION CRC LIMITED (AU) 2009-11-05 US disclosed
US-20090276042-A1 Biological Polysiloxanes VISION CRC LIMITED (AU) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090276042-A1 Biological Polysiloxanes PBK, B2M, CD79B PTGS1 2635/4885MEN1 782/4885KMT2A 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.